The European Commission’s R&D toolbox in the COVID-19 outbreak includes extended deadlines in Horizon 2020, additional funding opportunities for viral research - and less red tape
Former EU chief science adviser Anne Glover discusses the UK’s handling of the COVID-19 epidemic and if the European Commission is lacking scientific leadership during the crisis
EU president Charles Michel says there is ‘strong common will’ between G7 countries to deliver coronavirus vaccine, following reports of big-money overture by president Trump to CureVac
Early stage human trials for vaccine against the virus are ‘days or weeks’ away, but it will take at least 12 – 18 months to complete safety and efficacy tests, and much more money is needed
All universities in Italy, Greece, Denmark, Poland, Ireland and Hungary are closed down, as EU education and research ministers meet online to discuss coordinated response
Universities are relying on digital technologies to keep operating and carry on teaching, while researchers are postponing field work and meetings, as Italian government places entire country under quarantine
Pierre Meulien, director of the Innovative Medicines Initiative wants to see pooling of international research efforts to help curb the spread of COVID-19 and develop treatments for the respiratory infection it causes
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.